BLLN

Conviction 100HealthcareScan · Fri, Jun 26, 2026

BLLN$118.00+5.13%

ResistanceSupportVol 14Insider sell

Vol MA14 953.98K

Mar 27Apr 15May 4May 20Jun 9Jun 26

BillionToOne, Inc.Diagnostics & Researchwww.billiontoone.com ↗

Price118.00

Change+5.13%

Gap-1.15%

Rel volume3.24×

Avg volume926.36K

Avg $ vol95.85M

SMA 20101.68

SMA 5091.75

SMA 200—

Price vs 50+28.62%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 92.24

RSI (14)67

MACD hist1.14

MACD crossbull · 3d

Stoch %K / %D97 / 89

ADX (14)23

+DI / −DI27 / 10

RSI divergence—

MACD divergence—

ATR %+6.39%

ADR %7.23%

52w high130.18

52w low64.03

From 52w high-9.36%

Above 52w low+84.29%

New 52w highNo

SqueezeFired

Bollinger width23.65%

%B1.18

Donchian pos97.48%

Donchian high118.77

Donchian low88.45

AVWAP (52w high)90.41

vs AVWAP high+30.51%

AVWAP (52w low)91.44

vs AVWAP low+29.05%

OBV trendUp

Chaikin MF (20)0.10

Today vs 20d3.24×

Avg vol (14d)953.98K

Avg vol (20d)926.36K

Avg $ vol (20d)95.85M

Market cap—

RS 3m (vs SPY)+33.97%

RS 6m (vs SPY)+9.34%

RS line new highYes

Trend template—

Technical rank91.8

1 week+12.22%

1 month+29.64%

3 months+65.17%

6 months+35.52%

1 year—

YTD+32.15%

P/E168.53

P/B2.48

P/S4.12

P/FCF79.94

EPS0.1400

Div yield—

ROE1.47%

ROA1.06%

Debt/Eq0.11

Current10.92

EV/EBITDA33.85

Gross margin68.32%

Net margin2.44%

Rev growth99.97%

EPS growth117.93%

Price target123.33

Target upside9.74%

Analyst ratingBuy

Institutional28.24%

Ent. value776.01M

Revenue108.39M

Net income17.97M

Gross profit79.1M

Free cash flow15.71M

IndustryDiagnostics & Research

ExchangeNasdaq

Shares out41.44M

Employees713

ListedThu, Nov 6, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank91.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance108.50

Support74.41

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BLLN

All disclosures →

No recent disclosed trades by Congress in BLLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLLN · 1 buy · 9 sells

Insider	Side	Shares	Value	Traded	Filed
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	2.89K	$300K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	230	$24K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	600	$59K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	1K	$100K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	2.46K	$249K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Exercise	10K	$28K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	1.7K	$171K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	2.36K	$240K	2026-06-15	2026-06-17
Tsao David Chief Technology Officer · Class A Common Stock · 2026-06-15	Sell	2.82K	$289K	2026-06-15	2026-06-17
ten Bosch John Roderick See Remarks · Class A Common Stock · 2026-06-15	Sell	1.42K	$144K	2026-06-15	2026-06-17

SEC filings

EDGAR filings in BLLN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.